Additive Effects of Alternative Nostril Breathing with Pharmacological Management on Dyspnea and Control Pause in Patients with Bronchial Asthma

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-45
SponsorFoundation University Islamabad

About this trial

Bronchial asthma is a widespread chronic condition charactrized by inflammation and narrowing of airways, leading to repeateted episodes of breathlessness, wheezing and labored breathing.Breathing exercises help to manage hyperventilation often seen in asthmatic patients. To handle respiratory complications asthmatics are advised to practise nasal breathing techniques in conjunction with their prescribed medications.

Eligibility criteria

Qualifiers

Adults: aged (18-45 years)

Gender: Both males and females

Grade1- Grade 4 on Modified MRC dyspnea scale

Asthma severity classes (intermediate, mild persistent and moderate persistent asthma) acc. to NAEPP national asthma education and prevention program guidlin

Disqualifiers

Patients having acute exacerbation of COPD or status asthmaticus

Patients diagnosed with acute infections

Patients unable to follow command/ instructions

Asthma patients with >40 sec control pause duration

Trial design

Treatments tested in this trial

  • Alternative nostril breathing
  • Pharmacological therapy

Treatment groups

32 Participants
are divided into 2 treatment groups